ID

21238

Beschrijving

Ultrasound Targeting for the Lumpectomy Cavity; ODM derived from: https://clinicaltrials.gov/show/NCT00583843

Link

https://clinicaltrials.gov/show/NCT00583843

Trefwoorden

Versies (1)
  1. 16-04-17 16-04-17 -
Geüploaded op

16 april 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Neoplasms NCT00583843

Engels

Eligibility Breast Neoplasms NCT00583843

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
ability to understand and the willingness to sign a written informed consent document.
Beschrijving

written informed consent ability

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0085732
patients must have histologically or cytologically confirmed breast carcinoma with voluntarily elected breast conservation techniques (i.e., lumpectomy)
Beschrijving

breast carcinoma histology or cytology, breast conservation techniques

Datatype

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0019638
UMLS CUI [1,3]
C0010819
UMLS CUI [2]
C0917927
age >18 years. breast cancer, while not restricted only to adult women, is rare in the younger population.
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
radiation indicated as a post-surgical adjuvant treatment for breast conservation.
Beschrijving

adjuvant radiation indicated

Datatype

boolean

Alias
UMLS CUI [1,1]
C1706721
UMLS CUI [1,2]
C1444656
life expectancy of greater than 6 months.
Beschrijving

life expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
karnofsky of greater or equal to 60
Beschrijving

ID.6

Datatype

boolean

the effects of radiation therapy on the developing human fetus at the recommended therapeutic dose can be abortifacient. for this reason, and because radiation therapy is known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
Beschrijving

adequate contraception

Datatype

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who have not recovered from adverse events due to agents administered more than 4 weeks earlier.
Beschrijving

drug adverse events

Datatype

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
the inability to visualize or reliably contour the lumpectomy cavity from the radiation oncology treatment planning ct scan.
Beschrijving

visibility of lumpectomy cavity in planning ct

Datatype

boolean

Alias
UMLS CUI [1,1]
C0475644
UMLS CUI [1,2]
C0851238
UMLS CUI [1,3]
C0205379
patients with known brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events.
Beschrijving

brain metastases

Datatype

boolean

Alias
UMLS CUI [1]
C0220650
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements in the opinion of the principal investigator.
Beschrijving

intercurrent illness limiting compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C3640977
UMLS CUI [1,2]
C1321605
pregnant women are excluded from this study because radiation therapy has the potential for teratogenic or abortifacient effects. because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with standard chemotherapeutic regimens (if applicable), breastfeeding should be discontinued if the mother is treated any adjuvant chemotherapy.
Beschrijving

pregnancy, breast feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Terug naar het begin van de pagina

Similar models

Eligibility Breast Neoplasms NCT00583843

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
written informed consent ability
Item
ability to understand and the willingness to sign a written informed consent document.
boolean
C0021430 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
breast carcinoma histology or cytology, breast conservation techniques
Item
patients must have histologically or cytologically confirmed breast carcinoma with voluntarily elected breast conservation techniques (i.e., lumpectomy)
boolean
C0678222 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0010819 (UMLS CUI [1,3])
C0917927 (UMLS CUI [2])
age
Item
age >18 years. breast cancer, while not restricted only to adult women, is rare in the younger population.
boolean
C0001779 (UMLS CUI [1])
adjuvant radiation indicated
Item
radiation indicated as a post-surgical adjuvant treatment for breast conservation.
boolean
C1706721 (UMLS CUI [1,1])
C1444656 (UMLS CUI [1,2])
life expectancy
Item
life expectancy of greater than 6 months.
boolean
C0023671 (UMLS CUI [1])
ID.6
Item
karnofsky of greater or equal to 60
boolean
adequate contraception
Item
the effects of radiation therapy on the developing human fetus at the recommended therapeutic dose can be abortifacient. for this reason, and because radiation therapy is known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
drug adverse events
Item
patients who have not recovered from adverse events due to agents administered more than 4 weeks earlier.
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
visibility of lumpectomy cavity in planning ct
Item
the inability to visualize or reliably contour the lumpectomy cavity from the radiation oncology treatment planning ct scan.
boolean
C0475644 (UMLS CUI [1,1])
C0851238 (UMLS CUI [1,2])
C0205379 (UMLS CUI [1,3])
brain metastases
Item
patients with known brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events.
boolean
C0220650 (UMLS CUI [1])
intercurrent illness limiting compliance
Item
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements in the opinion of the principal investigator.
boolean
C3640977 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
pregnancy, breast feeding
Item
pregnant women are excluded from this study because radiation therapy has the potential for teratogenic or abortifacient effects. because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with standard chemotherapeutic regimens (if applicable), breastfeeding should be discontinued if the mother is treated any adjuvant chemotherapy.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial